Eli Lilly Gains from Big Earnings, Bullish Inflows
LLY is one of the world’s most valuable healthcare companies, having created medicines for diabetes, oncology, immunology, neuroscience, and obesity, along with using advanced technologies and AI to make more treatments. The company’s third-quarter fiscal 2025 earnings report, LLY showed $59.4 billion in revenue, a net margin of 31%, earnings growth of 116.6% in a year,
» Read more about: Eli Lilly Gains from Big Earnings, Bullish Inflows »